Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10070579 | European Journal of Surgical Oncology (EJSO) | 2005 | 5 Pages |
Abstract
The abundant expression of EZH-2 in CRC cases indicated that EZH-2 may be an oncogene and a prognostic marker for CRC cases. We discovered there was concordant expression of HDAC-1 with EZH-2 in clinical CRC cases, in addition to the fact that higher expression levels of both genes predicted a poor prognosis.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
K. Mimori, K. Ogawa, M. Okamoto, T. Sudo, H. Inoue, M. Mori,